PharmaCielo Ltd.
PCLO.V
TSX
| 06/30/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -10.31M | -10.43M | -10.43M | -11.22M |
| Total Depreciation and Amortization | -- | 565.50K | 640.00K | 854.10K | 871.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 6.20M | 5.82M | 5.60M | 5.06M |
| Change in Net Operating Assets | -- | 1.28M | 1.44M | 1.44M | 2.01M |
| Cash from Operations | -- | -2.26M | -2.54M | -2.54M | -3.28M |
| Capital Expenditure | -- | -3.90K | -4.30K | -4.30K | -2.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 74.60K | 117.80K | 117.80K | 159.40K |
| Cash from Investing | -- | 70.70K | 113.50K | 113.50K | 157.20K |
| Total Debt Issued | -- | 2.99M | 3.65M | 3.84M | 4.48M |
| Total Debt Repaid | -- | -856.40K | -862.70K | -862.70K | -801.20K |
| Issuance of Common Stock | -- | 607.00K | 425.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 237.00K | 0.00 | 237.00K | 237.00K |
| Cash from Financing | -- | 2.19M | 2.37M | 2.37M | 2.90M |
| Foreign Exchange rate Adjustments | -- | 7.50K | 7.40K | 7.40K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 2.20K | -47.90K | -47.90K | -212.20K |